EORTC-20971-22997-LYMG-ROG

Back to Clinical Trials Database

A Phase III randomized study on low-dose total body irradiation and involved field radiotherapy in patients with localized, stages I and II, low grade non-Hodgkin's lymphoma

Study documentation

Trial Status	All trial activities ended
Dates	Date of activation: 25-Jan-2001 Date Step1 close: 02-Mar-2009
Data management at EORTC	Yes
Design	Phase 3 Randomized open label
Targeted Sample size	EORTC Groups: 344 - All Groups: 344
Treatment	Radiotherapy
Study Staff	Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels Cedric Mallien (Clinical Operations Manager) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Ward Sents (Clinical Scientist) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer	Non Hodgkins Lymphoma
Participating groups	EORTC Lymphoma Group EORTC Radiation Oncology Group
Recruiting centers	Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Brescia, Italy) Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France) Instituut Verbeeten (Tilburg, Netherlands) Maastro Clinic - Maastricht Radiation Oncology (Maastricht, Netherlands) Medisch Spectrum Twente (Enschede, Netherlands) National Cancer Institute - Cairo (Cairo, Egypt) Rigshospitalet (Copenhagen, Denmark) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands) University Hospital Centre Zagreb (Zagreb, Croatia)
Centers to be activated	A.Z. St. Jan (Brugge, Belgium) General Teaching Hospital In Prague (Prague 2, Czech Republic) Institut Jules Bordet (Anderlecht, Belgium) Royal Wolverhampton NHS - New Cross Hospital (Wolverhampton West Midlands, United Kingdom)
Protocol summary	http://clinicaltrials.gov/study/NCT00014326
NCT number	NCT00014326
Financial Support	EORTC HQ